Busque entre los 168782 recursos disponibles en el repositorio
Mostrar el registro sencillo del ítem
dc.date.accessioned | 2010-04-06T18:22:57Z | |
dc.date.available | 2010-04-06T03:00:00Z | |
dc.date.issued | 2010 | es |
dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/7890 | |
dc.description.abstract | Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 have been used as tools for the screening of anti-inflammatory agents. In a search for inhibitors of COX-2 and iNOS, we found that extracts of Enteromorpha prolifera inhibit the production of nitric oxide (NO) and prostaglandin (PG)E2 in LPS-stimulated RAW 264.7 macrophage cells. We first extracted E. prolifera with 80% ethanol and the extract was partitioned with hexane, dichloromethane, ethyl acetate, butanol, and water, successively. The results indicate that the hexane and ethyl acetate fractions effective inhibited LPS-induced NO and PGE2 production in RAW 264.7 cells. To test the inhibition effects of the E. prolifera fractions on other cytokines, we also performed an ELISA assay on tumor necrosis factor (TNF)-α, IL-1β, and IL-6 in LPS-stimulated RAW 264.7 macrophage cells. The expression of TNF-α, IL-1β, and IL-6 was also decreased following treatment with the hexane and ethyl acetate fractions. To test the potential application of the E. prolifera extract as a cosmetic material, we also performed MTT assays on keratinocyte HaCaT cells as well as primary skin irritation tests. In these assays, the E. prolifera extracts did not induce any adverse reactions. Based on these results, we suggest that E. prolifera extracts may be considered potential anti-inflammatory candidates for skin health. | es |
dc.format.extent | 165-170 | es |
dc.language | en | es |
dc.subject | cytokine; enteromorpha prolifera; inflammation; iNOS; PGE2 | es |
dc.subject | Agentes antiinflamatorios | es |
dc.title | Inhibitory effects of Enteromorpha prolifera on the production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 cells | es |
dc.type | Articulo | es |
sedici.identifier.uri | http://www.latamjpharm.org/resumenes/29/2/LAJOP_29_2_1_1.pdf | es |
sedici.creator.person | Yoon, Weon-Jong | es |
sedici.creator.person | Kim, Dong Sam | es |
sedici.creator.person | Yang, Eun-Jin | es |
sedici.creator.person | Moon, Ji-Young | es |
sedici.creator.person | Kim, Min-Jin | es |
sedici.creator.person | Lee, Wook Jae | es |
sedici.creator.person | Lee, Nam Ho | es |
sedici.creator.person | Hyun, Chang-Gu | es |
sedici.subject.materias | Farmacia | es |
sedici.description.fulltext | false | es |
mods.originInfo.place | Colegio de Farmacéuticos de la Provincia de Buenos Aires | es |
sedici.subtype | Articulo | es |
sedici2003.identifier | ARG-FARM-ART-0000001376 | es |
sedici.relation.journalTitle | Latin American Journal of Pharmacy | es |
sedici.relation.journalVolumeAndIssue | vol. 29, no. 2 | es |